Pierre Fabre Overview
- Year Founded
-
1962
- Status
-
Private
- Employees
-
10,000
Pierre Fabre General Information
Description
Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medical innovation. The company's services are offered through an innovation laboratory that promotes research and development in pharmaceuticals, cosmetics and biotechnological domains so as to develop new drugs and health-friendly products without using chemicals and toxic ingredients, enabling medical researchers to recommend and develop all natural healthcare products abiding by the legal compliance and governmental regulations.
Contact Information
Website
www.pierre-fabre.comCorporate Office
- 12, Avenue Hoche
- 75008 Paris
- France
Corporate Office
- 12, Avenue Hoche
- 75008 Paris
- France
Pierre Fabre Comparisons
Industry
Financing
Details
Pierre Fabre Competitors (18)
One of Pierre Fabre’s 18 competitors is Douglas (Pharmaceuticals and Biotechnology), a Corporation company based in Auckland, New Zealand.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Douglas (Pharmaceuticals and Biotechnology) | Corporation | Auckland, New Zealand | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| Lilly USA | Corporation | Indianapolis, IN |
Pierre Fabre Patents
Pierre Fabre Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026087699-A1 | New treatment of non-small cell lung cancer | Pending | 24-Oct-2024 | ||
| FR-3159741-A1 | Topical formulation comprising binimetinib | Pending | 04-Mar-2024 | ||
| WO-2025186275-A1 | Topical formulation comprising binimetinib | Pending | 04-Mar-2024 | ||
| WO-2025186275-A8 | Topical formulation comprising binimetinib | Pending | 04-Mar-2024 | ||
| FR-3159747-A1 | Combination for the treatment of halitosis | Pending | 29-Feb-2024 | A61P1/02 |
Pierre Fabre Signals
Pierre Fabre Investments & Acquisitions (17)
Pierre Fabre’s most recent deal was a Corporate Asset Purchase with Antares Therapeutics (Global Assets Of PFL- 721 and PFL-241). The deal was made on 16-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Antares Therapeutics (Global Assets Of PFL- 721 and PFL-241) | 16-Jun-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Kinnate Biopharma (Exarafenib And Other Pan-RAF Program Assets) | 27-Feb-2024 | Corporate Asset Purchase | Buildings and Property | ||
| TOLREMO therapeutics | 20-Sep-2023 | Later Stage VC | Drug Discovery | ||
| Vertical Bio | 14-Aug-2023 | Merger/Acquisition | Biotechnology | ||
| Même | 12-Apr-2023 | Merger/Acquisition | Personal Products |
Pierre Fabre Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Même | Paris, France | 2015 | |
| Pierre Fabre Invest | Castres, France | 2007 | |
| Urogene | Paris, France | 1998 | |
| Ladrôme Laboratoire | Saillans, France | 1993 | |
| Pierre Fabre (United States Rights For Hemangeol) |
Pierre Fabre FAQs
-
When was Pierre Fabre founded?
Pierre Fabre was founded in 1962.
-
Where is Pierre Fabre headquartered?
Pierre Fabre is headquartered in Paris, France.
-
What is the size of Pierre Fabre?
Pierre Fabre has 10,000 total employees.
-
What industry is Pierre Fabre in?
Pierre Fabre’s primary industry is Pharmaceuticals.
-
Is Pierre Fabre a private or public company?
Pierre Fabre is a Private company.
-
What is Pierre Fabre’s current revenue?
The current revenue for Pierre Fabre is .
-
Who are Pierre Fabre’s competitors?
Douglas (Pharmaceuticals and Biotechnology), Novartis, Evonile Pharma, Roche, and Lilly USA are some of the 18 competitors of Pierre Fabre.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process